Carcinogenicity of anticancer drugs and especially alkylating agents
- PMID: 3583394
Item in Clipboard
Carcinogenicity of anticancer drugs and especially alkylating agents
IARC Sci Publ.
1986.
No abstract available
Similar articles
-
Carcinogenicity of alkylating cytostatic drugs. Proceedings of a symposium. Heidelberg, Federal Republic of Germany, 25-27 November 1985.IARC Sci Publ. 1986;(78):1-338. IARC Sci Publ. 1986. PMID: 3583383 No abstract available.
-
Structure-activity relationships in the carcinogenicity of anticancer agents.Drug Metab Rev. 1984;15(3):619-46. doi: 10.3109/03602538409029975. Drug Metab Rev. 1984. PMID: 6386411 Review. No abstract available.
-
[Carcinogenicity of anticancer agents].Gan To Kagaku Ryoho. 1990 Dec;17(12):2293-8. Gan To Kagaku Ryoho. 1990. PMID: 2260866 Review. Japanese.
-
[Side-effects of cytostatic therapy with special reference to potential carcinogenic effects].Internist (Berl). 1971;12:Suppl 1:115-9. Internist (Berl). 1971. PMID: 5002614 Review. German. No abstract available.
-
[Carcinogenic effects of antineoplastic and immunosuppressive agents].Arzneimittelforschung. 1971 Sep;21(9):1406-10. Arzneimittelforschung. 1971. PMID: 5171799 German. No abstract available.
Cited by
-
In vivo and in vitro investigations on biological effects of aromatic bis-(2-chloroethyl)amino-bisphosphonic acids, new agents proposed for chemotherapy of bone tumors: cytostatic activity in rat osteosarcoma; toxicity and genotoxicity in liver and bone marrow; mutagenicity in S. typhimurium.Invest New Drugs. 1988 Jun;6(2):67-78. doi: 10.1007/BF00195363. Invest New Drugs. 1988. PMID: 3049432